VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1824408
Sex: F
Age:
State: NY

Vax Date: 04/21/2021
Onset Date: 05/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: This is a spontaneous report from a contactable nurse. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an intramuscular route of administration in the right arm on 21Apr2021 at 11:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis (RA), osteoarthritis, fibromyalgia and known allergies to sulfa and invisible sutures. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included pravastatin (MANUFACTURER UNKNOWN) and celecoxib (CELEBREX), all from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously took erythromycin (MANUFACTURER UNKNOWN) and terbinafine(LAMISIL) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration on 31Mar2021 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 01May2021 at 01:00, the patient experienced a bump on her forearm that appeared on 01May2021 and then her shoulder was read and swollen with bumps and very painful. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with gabapentin (MANUFACTURER UNKNOWN), ciprofloxacin (CIPRO) and prednisone (MANUFACTURER UNKNOWN). Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events bump on her forearm, shoulder was read and swollen with bumps and very painful was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PRAVASTATIN; CELEBREX

Current Illness:

ID: 1824409
Sex: F
Age:
State:

Vax Date: 03/28/2021
Onset Date: 04/11/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 28Mar2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medication. On 11Apr2021, the patient experienced blockage in the eustatian tube (ear). The patient had no allergies or recent cold which could have caused this and diagnosis was completed by an ENT doctor. The event resulted in doctor or other healthcare professional office or clinic visit. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of event blockage in the eustatian tube (ear) which included treatment with flonase (MANUFACTURER UNKNOWN) nasal spray to clear the blockage. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event blockage in the eustatian tube (ear) was not resolved at the time of this report. The patient had received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824410
Sex: F
Age:
State: VA

Vax Date: 04/17/2021
Onset Date: 04/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Early mensuration and started bleeding both times the very next day for a few days and then it stopped; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 13:00 (at the age of 40-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08May2021 at 12:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL) 30 mg once a day (1Xday), melatonin (MANUFACTURER UNKNOWN) and unspecified multivitamins; all for unknown indications from an unknown date and unknown if ongoing. On Apr2021, besides the normal side effects both shorts, the patient experienced early mensuration and started bleeding both times the very next day for a few days and then it stopped. The patient was assuming it was from the vaccine and she could not put in both dates but this happened with the first and second vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of events besides the normal side effects both shorts, the patient experienced early mensuration and started bleeding both times. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event early mensuration and started bleeding both times was recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected. .

Other Meds: ADDERALL; MELATONIN

Current Illness:

ID: 1824411
Sex: M
Age:
State: CA

Vax Date: 04/29/2021
Onset Date: 05/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: "I" received the second Pfizer vaccine on April 29.On the evening of Saturday May 1, "I" noticed a rash beginning to form around "my" right nipple; A small lump under "my" right nipple.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO172) via an unspecified route of administration in the left arm on 29Apr2021 at 11:30(at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERB729) via an unspecified route of administration in the left arm on 08Apr2021 at 14:00(at the age of 55-years-old) as a single dose for COVID-19 immunisation. On 01May2021 at 20:00, in the evening, the patient noticed a rash which began to form around his right nipple and small lump under his right nipple. By 03May2021, the rash and the lump had tripled in size, on 05May2021, the rash and lump had begun to subside. On 06May2021, patient met with his doctor for a physical. The doctor said that was possible the rash and lump were a side effect of the vaccine. On 07May2021, the rash and the lump are almost gone. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash beginning to form around the right nipple and a small lump under right nipple was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824412
Sex: F
Age:
State: MN

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 29Mar2021(at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity and allergy to macadamia nuts. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included buspirone (MANUFACTURER UNKNOWN), adults vitamins and NSRI prescription from an unknown date for unspecified indication and unknown if ongoing. The patient previously took cefalexin (KEFLEX) and codeine (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 08Mar2021(at the age of 50-years-old) as a single dose for COVID-19 immunisation. On 29Mar2021, several hours after the vaccination the patient experienced hemorrhoids and lasted roughly two days, then resolved. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the reported event and included treatment with the product preparation H cream. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event hemorrhoids was recovered on 31Mar2021, after the duration of 2 days. No follow-up attempts are needed. No further information is expected.

Other Meds: BUSPIRONE.

Current Illness:

ID: 1824413
Sex: F
Age:
State: MA

Vax Date: 05/03/2021
Onset Date: 05/04/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210504; Test Name: Body temperature; Result Unstructured Data: Test Result:102 degrees; Comments: fever up to 102 degrees for next 24 hours

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: 12 hours later flu like symptoms; Chills; Bodyache; Fever up to 102 degrees for next 24 hours; Followed by severe headache and nausea that lasted next 48 hours straight. Day 4 and 5 on and off headaches; Nausea that lasted next 48 hours straight; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03May2021 at 18:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer in 2014, smoker, anxiety and chronic inflammatory lung disease (COPD). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included alprazolam (XANAX), ascorbic acid (VITAMIN C) and zinc (MANUFACTURER UNKNOWN); all from unknown date for unknown indication and unknown if ongoing. The patient previously took hydrocodone bitartrate; paracetamol (VICODIN) and experienced adverse effects. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Apr2021 at 17:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 05:00, 12 hours later the patient experienced flu like symptoms, bodyache, chills, fever up to 102 degrees (units unspecified) for next 24 hours. Followed by severe headache and nausea that lasted next 48 hours straight. Day 4 and 5 she had on and off headaches. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events flu like symptoms, bodyache, chills, fever up to 102 degrees (units unspecified) for next 24 hours was resolved with sequelae on 05May2021. The clinical outcome of the events severe headache and nausea that lasted next 48 hours straight; day 4 and 5 had on and off headaches was resolved with sequelae on an unknown date in May2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: XANAX; VITAMIN C [ASCORBIC ACID]; ZINC

Current Illness:

ID: 1824414
Sex: F
Age:
State: MA

Vax Date: 05/04/2021
Onset Date: 05/06/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: After receiving vaccine, started to experience hives that come and go. They are welt-like and tend to appear after showering and in the evenings. They are centered around lower back and waist area, but occasionally appear on neck and arms; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 04May2021 at 17:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient was allergic to shellfish. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol, norgestimate (TRI-SPRINTEC), taken for birth control from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 13Apr2021 at 17:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 22:30, after receiving the vaccine, the patient started to experience hives that came and went. They were welt-like and had tend to appear after showering and in the evenings. They were centered around her lower back and waist area, but occasionally appeared on her neck and arms. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event after receiving the vaccine experienced hives that came and went, they were welt-like and tend to appear after showering and in the evenings and centered around her lower back and waist area, but occasionally appeared on her neck and arms was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TRI-SPRINTEC

Current Illness:

ID: 1824415
Sex: F
Age:
State: MI

Vax Date: 04/28/2021
Onset Date: 04/30/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Mostly long term gastrointestinal gas; Nausea; Exhaustion; Some brain fog; Almost flue like; Diarrhea, symptoms not getting better; No able to function as normal.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 28Apr2021 at 15:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included environment illness and chronic inflammation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received pentazocine (TALWIN), codeine (MANUFACTURER UNKNOWN), bupropion hydrochloride (WELLBUTRIN), cortisone (MANUFACTURER UNKNOWN) and fluoroquinolone (MANUFACTURER UNKNOWN), for unknown indication from an unknown date and experienced drug allergy. On 30Apr2021, the patient experienced mostly long term gastrointestinal gas and nausea, exhaustion, some brain fog. Overall, in well, almost flu like. Diarrhea, symptoms were not getting better and not able to function as normal. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events mostly long term gastrointestinal gas, nausea, exhaustion, some brain fog (foggy feeling in head), flu like and diarrhea was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824416
Sex: F
Age:
State: CA

Vax Date: 04/30/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Shortness of breath; Tight chest; chest muscle pain.; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 30Apr2021 at 08:45(at the age of 35-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included unspecified prenatals from an unknown date for an unknown indication and unknown if ongoing. On 07May2021 at 08:00, the patient experienced shortness of breath, tight chest and chest muscle pain. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shortness of breath, tight chest and chest muscle pain were not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824417
Sex: F
Age:
State: MI

Vax Date: 05/04/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Left arm was injection location, was very sore; Left arm is the injection location, swollen; Left arm was the injection location, red; Left arm was the injection location, hot to the touch.; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 04May2021 at 13:00 (at the age of 58-year-old) as a 0.3 mL single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 13Apr2021 at 13:00 (at the age of 58-year-old) as a 0.3 mL single dose for COVID-19 immunisation. On 07May2021, the patient experienced left arm, which was her injection location, was very sore, swollen, red and hot to the touch. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm which was injection location, was very sore, swollen, red and hot to the touch was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824418
Sex: F
Age:
State: TX

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Severe chills; Body aches; Musculoskeletal issues in upper back; Dose 1: 08Apr2021; Dose 2: 22Apr2021; Have not felt like myself since dose 2; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 22Apr2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included gastrointestinal ischemia. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant therapies were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 08Apr2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021, the patient had not felt like herself since dose 2. On 23Apr2021 at 22:45 the patient experienced severe chills, body aches and musculoskeletal issues in upper back. The patient also reported that chiropractor also informed her that he has seen several patients develop strange musculoskeletal issues following dose 1 or 2 of the vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of not felt like herself since dose 2, severe chills, body aches and musculoskeletal issues in upper back and included treatment under chiropractor's care and taking anti-inflammatory medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events not felt like herself since dose 2, severe chills, body aches and musculoskeletal issues in upper back were recovered with sequelae. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824419
Sex: F
Age:
State: FL

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: High fever; Chills; Throbbing pain through the entire arm radiating to the wrist ( left arm)/ Sore mid part of body; Sore throat; Swollen neck lymph nodes; Excessive sweating; Headache; Insomnia; Lower back pain; Sensitive to touch mid part of the body; Muscle pain; Joint pain; Excessive vaginal discharge; Dizziness; Throbbing pain through the entire arm; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05May2021 at 11:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified contraceptive pills from unknown date and unknown if ongoing. The patient did not receive other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 14Apr2021 at 14:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 23:30, the patient experienced high fever, chills, throbbing pain through the entire arm radiating to the wrist (left arm), sore throat, swollen neck lymph nodes, excessive sweating, headache, insomnia, lower back pain, sore, sensitive to touch mid part of the body, muscle and joint pain, excessive vaginal discharge, and dizziness. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events high fever, chills, throbbing pain through the entire arm radiating to the wrist (left arm), sore throat, swollen neck lymph nodes, excessive sweating, headache, insomnia, lower back pain, sore, sensitive to touch mid part of the body, muscle and joint pain, excessive vaginal discharge, and dizziness was resolving at the time of this report. No follow-up attempts are required, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824420
Sex: F
Age:
State: NH

Vax Date: 03/22/2021
Onset Date: 03/23/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Headache; Chills; Exhaustion; Stiff Neck; Sores on Roof of Mouth; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 22Mar2021 at 18:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to penicillin from an unknown date and prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021, the patient experienced headache, chills, exhaustion, stiff neck and sores on roof of mouth. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, chills, exhaustion, stiff neck and sores on roof of mouth was resolved with sequelae on an unknown date in 2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 12Apr2021 at 12:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824421
Sex: F
Age:
State: MD

Vax Date: 05/03/2021
Onset Date: 05/04/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Redness at injection site for 3 full days after the 2nd shot; large bump/swelling at injection site for 3 full days; swelling at injection site for 3 full days; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03May2021 at 11:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy (sulfonaminde allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included multivitamins (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D3) and riboflavin (VITAMIN B2) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr 2021 at 11:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 12:00, after the second shot the patient experienced redness, large bump and swelling at injection site for 3 full days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events redness, large bump and swelling at injection site for 3 full days was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: VITAMIN D3; VITAMIN B2 [RIBOFLAVIN]

Current Illness:

ID: 1824422
Sex: M
Age:
State: NJ

Vax Date: 05/06/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the right arm on 06May2021 at 15:00 (at the age of 56-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on an unknown date in Apr2021 at 15:00 (at the age of 56-year-old), as a single dose for COVID-19 immunisation. On 07May2021 at 01:00, the patient experienced low grade fever, chills, body aches and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the reported events and included treatment with paracetamol (TYLENOL) from an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event low-grade fever, chills, body aches and fatigue was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824423
Sex: F
Age:
State: CO

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Moderate aches in lower back for about 18 hours; Sore lymph nodes right side only about 16 hours; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 05May2021 at 09:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not had any medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0164) via an unspecified route of administration in the left arm on 15Apr2021 at 09:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 09:30, the patient experienced moderate aches in lower back for about 18 hours and sore lymph nodes right side only about 16 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore lymph nodes right side only was resolved on 06May2021 at 01:30, after the duration of 16 hrs and moderate aches in lower back resolved on 06May2021 at 03:30, after the duration of 18 hrs. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824424
Sex: M
Age:
State: TX

Vax Date: 04/25/2021
Onset Date: 05/04/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Left supraclavicular lymphadenopathy; This is a spontaneous report from a contactable consumer, the physician. A 61-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an intramuscular route of administration in the left arm on 25Apr2021 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history reported as the patient need to release the information. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included methylphenidate (MANUFACTURER UNKNOWN), venlafaxine (MANUFACTURER UNKNOWN) and rosuvastatin (MANUFACTURER UNKNOWN); all for unknown indication, from an unknown start date and unknown if on going. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04May2021, the patient experienced left supraclavicular lymphadenopathy, no other lymphadenopathy was found and no other symptoms. The reporter tried to speak to someone at Pfizer to see if this particular side effect has occurred with this vaccine, but was unable to get a person on the telephone. If someone could call him, he told he would appreciate it and given his office contact number. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event left supraclavicular lymphadenopathy was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: METHYLPHENIDATE; VENLAFAXINE; ROSUVASTATIN

Current Illness:

ID: 1824425
Sex: M
Age:
State:

Vax Date: 04/16/2021
Onset Date: 04/24/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210427; Test Name: COVID-19 test; Result Unstructured Data: Test Result:Negative

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Axillary lymphadenopathy in same arm as vaccine/ Very painful and red swollen lymph node; Very painful and red swollen lymph node; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 16Apr2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications. On 24Apr2021, the patient experienced axillary lymphadenopathy in same arm as vaccine about a week after injection and also experienced very painful and red swollen lymph node. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with unspecified antibiotics and the patient's condition was improving. On 27Apr2021, the patient underwent COVID-19 test (reported as other) and the result was negative. The clinical outcome of the events axillary lymphadenopathy in same arm as vaccine/ very painful and red swollen lymph node and very painful and red swollen lymph node was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824426
Sex: F
Age:
State: CA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Migraine; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 14Apr2021 at 11:15 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 14Apr2021 at 12:00, the patient experienced migraine headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event migraine headache was resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824427
Sex: F
Age:
State: NJ

Vax Date: 04/21/2021
Onset Date: 04/26/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Extreme fatigue; Chest pressure; Head pressure; Tremors; pins and needles throughout body; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 21Apr2021 at 10:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and irritable bowel syndrome (IBS) and Known allergies to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received ampicillin sodium/sulbactam sodium (UNASYN) for an unknown indication on an unknown date and experienced drug allergy. On 26Apr2021 at 08:00, the patient experienced extreme fatigue, chest pressure, head pressure, tremors and pins and needles throughout body. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme fatigue, chest pressure, head pressure, tremors and pins and needles throughout body was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824428
Sex: F
Age:
State: FL

Vax Date: 04/19/2021
Onset Date: 04/20/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Flu test; Test Result: Negative ; Comments: Negative tests for the following: strep, mono, elevated WBC, COVID, flu A or B; Test Date: 2021; Test Name: Blood test; Result Unstructured Data: Test Result:Unknown; Comments: Negative tests for the following: strep, mono, elevated WBC, COVID, flu A or B; Test Date: 2021; Test Name: Monospot test; Test Result: Negative ; Comments: Negative tests for the following: strep, mono, elevated WBC, COVID, flu A or B; Test Date: 2021; Test Name: Strep test; Test Result: Negative ; Comments: Negative tests for the following: strep, mono, elevated WBC, COVID, flu A or B; Test Date: 20210503; Test Name: PCR test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Extreme fatigue; Headache; Sore throat; Mouth sores; Diagnosed with lichen planus; gums and palate swollen and red; gums and palate swollen and red; gums and palate swollen and red; gums and palate swollen and red; Aches; Chills; Fever; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 19Apr2021 at 17:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included mono as a teenager. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7S34) via an unspecified route of administration in the left arm on 29Mar2021 at 17:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation and received hyoscine (SCOPOLAMINE) for an unknown indication on an unknown date and experienced drug allergy. On 20Apr2021, day after 2nd shot, the patient experienced aches, chills and fever and over in 24 hours. On 29Apr2021, 10 days after 2nd shot, the patient experienced gums and palate swollen and red. On 30Apr2021, next day, the patient started with fever, extreme fatigue, headache, sore throat, aches, chills, mouth sores developed next to the negative tests for the following: strep, mono, elevated WBC, COVID, flu A or B and was diagnosed with lichen planus. Now, 7 days later, the patient still had unexplained fever, headache and mouth sores. By the way the patient did not agree with our privacy policy as it relates to anything besides the effects of the vaccine, but she felt this needs to be reported in the public interest. On 03May2021, the patient underwent PCR test (nasal swab) and the result was Negative. The events result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the mouth sores and included treatment with oral steroid. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events aches, chills, fever, gums and palate swollen and red, extreme fatigue, headache, sore throat, mouth sores and lichen planus was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824429
Sex: F
Age:
State: NJ

Vax Date: 04/29/2021
Onset Date: 04/30/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Extreme Muscle & Joint Pain; Extreme Muscle & Joint Pain; Swelling; Rash; Pain at injection site; Drowsy as if drugged; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 29Apr2021 at 13:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, osteoarthritis, sciatica and shellfish allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metformin (MANUFACTURER UNKNOWN) and loratadine (CLARITIN) both for an unknown indication from an unknown date and were unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 08Apr2021 at 13:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. On 30Apr2021 at 12:00, the patient experienced exhaustion, extreme muscle and joint pain, swelling, rash, pain at injection site and drowsy as if drugged. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events exhaustion, extreme muscle and joint pain, swelling, rash, pain at injection site and drowsy as if drugged were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; CLARITIN [LORATADINE]

Current Illness:

ID: 1824430
Sex: F
Age:
State: PA

Vax Date: 04/29/2021
Onset Date: 04/29/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Headache; Body aches; Extreme tiredness; Body heaviness; This is a spontaneous report from a non-contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Apr2021 at 23:45 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took modafinil (PROVIGIL) and cisapride (PROPULSID) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12Apr2021 at 12:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 29Apr2021 the patient experienced headache, body aches, extreme tiredness and body heaviness lasting through the next day. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with alternate paracetamol (TYLENOL) and ibuprofen (ADVIL) as per doctor instruction. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, body aches, extreme tiredness and body heaviness were resolved on an unknown date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824431
Sex: F
Age:
State: IL

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Fever; Chills; Sharp pain on top of head and right shoulder; Sharp pain on top of head and right shoulder; Felt like a pin was pricking right shoulder and right side of neck; My molars were on edge - both sides; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05May2021 at 15:55 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamins (MANUFACTURER UNKNOWN)) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 14Apr2021 at 16:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 16:30, 35 minutes after shot the patient experienced sharp pain on top of head and right shoulder when the patient was driving home. This did not last more than a minute. Then, the patient felt like a pin was pricking on right shoulder and right side of neck. The patient molars were on edge both sides. The patient experienced all of these strange reactions while driving home in the car and were gone within 30 minutes. On 06May2021 at 09:30, beginning the next day the patient experienced fever and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sharp pain on top of head and right shoulder, pin was pricking right shoulder and right side of neck and molars were on edge both sides were recovered on 05May2021 at 17:00. The clinical outcome of the events fever and chills were recovered on an unknown date in May2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824432
Sex: F
Age:
State: SC

Vax Date: 05/06/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Extremely swollen and tender lymph nodes under left arm/in left armpit; Extremely swollen and tender lymph nodes under left arm/in left armpit; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 06May2021 at 11:45 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 15Apr2021 at 11:45 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. On 07May2021, the patient experienced extremely swollen and tender lymph nodes under left arm/in left armpit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely swollen and tender lymph nodes under left arm/in left armpit were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824433
Sex: F
Age:
State: MD

Vax Date: 05/05/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Swelling of lymph nodes in armpit; This is a spontaneous report from a contactable health care professional, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 05May2021 at 15:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within 4 weeks prior to the vaccination. Concomitant medications included bupropion hydrochloride (WELLBUTRIN); buspirone (MANUFACTURER UNKNOWN) and alprazolam (XANAX); all for unknown indication started on an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8732) via an unspecified route of administration in the right arm on 14Apr2021 at 18:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 07May2021 at 07:30, 48 hours after vaccination, the patient experienced swelling of lymph nodes in armpit. Therapeutic measures were not taken as a result of the event. The event did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swelling of lymph nodes in armpit was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: WELLBUTRIN; BUSPIRONE; XANAX

Current Illness:

ID: 1824434
Sex: F
Age:
State: RI

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: I had very bad insomnia; anxiety; extreme fatigue; brain fog for over a week after the vaccine; Later I had night sweats.; This is a spontaneous report from a non-contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267-1000-01) via an unspecified route of administration in the left arm on 03Apr2021 at 12:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), vitamins (MANUFACTURER UNKNOWN) and herbs (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously did not take any drug in the past. On 03Apr2021, the patient had very bad insomnia, anxiety, extreme fatigue and brain fog for over a week after the vaccine. Later patient had night sweats. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of anxiety and included treatment with lorazepam (MANUFACTURER UNKNOWN) and homeopathic remedies. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very bad insomnia, anxiety, extreme fatigue and brain fog was recovered on an unknown date in Apr2021. The clinical outcome of the event later I had night sweats was recovered on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: ALLEGRA

Current Illness:

ID: 1824435
Sex: F
Age:
State: IN

Vax Date: 04/27/2021
Onset Date: 05/10/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210419; Test Name: COVID-19 test; Test Result: Negative

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Once my period started it was way worse cramps; A heavier flow than i've ever had; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the right arm on 27Apr2021 at 14:15 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient underwent COVID-19 test and the result was negative. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 04Apr2021 at 14:15 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. On 10May2021, once the patients period started it was way worse cramps and a heavier flow than she ever had. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events once period started it was way worse cramps and a heavier flow than she ever had was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824436
Sex: F
Age:
State: NC

Vax Date: 04/21/2021
Onset Date: 04/23/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 21Apr2021 at 13:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included mitral valve prolapse, degenerative disc disease, migraines, raynaud's disease, menopause and known allergies to penicillin. Prior to vaccination, the patient was not diagnosed with COVID -19. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and sennoside a+b (EX-LAX); both for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received sulfamethoxazole/trimethoprim (BACTRIM) for an unknown indication on an unknown date and experienced drug allergy. On 23Apr2021 at 01:15, within 36 hours of the first vaccine, the patient began to have vertigo and got bad enough that she could not stand or move her head. The patient became very weak and nauseous. The patient was extremely fatigued and subsequently determined that she was having complicated migraines possibly triggered by the vaccine. It had happened 3 times and the patient's second dose was due today (as reported). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vertigo, got bad enough that she could not stand or move her head, very weak, nauseous, extremely fatigued and complicated migraines possibly triggered by the vaccine was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN; EX-LAX [SENNOSIDE A+B].

Current Illness:

ID: 1824437
Sex: M
Age:
State: PA

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Burning pain in joints / knees; Visual issues (flashing / swirling in peripheral); Significant chills; Significant nausea; Vomiting; Rash/swelling around eyes; Swelling around eyes; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 04May2021 at 09:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive concomitant medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 13Apr2021 at 09:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the vaccination. On 04May2021 at 18:00, the patient experienced burning pain in joints and knees, visual issues like flashing and swirling in peripheral, significant chills, significant nausea and vomiting, rash and swelling around eyes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events burning pain in joints and knees, visual issues like flashing and swirling in peripheral, significant chills, significant nausea and vomiting, rash and swelling around eyes were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824438
Sex: F
Age:
State: IA

Vax Date: 05/03/2021
Onset Date: 05/03/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Extreme fatigue for 7 days; Lightheadedness; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 03May2021 at 09:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history reported that the patient's colon removed due to ulcerated colitis in 1992. The patient had known allergies to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fish oil (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), cyanocobalamin (VITAMIN B12) and loperamide (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 08Apr2021 at 09:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. On 03May2021 at 18:00, the patient experienced extreme fatigue for 7 days and lightheadedness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as results of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme fatigue for 7 days and lightheadedness was resolved on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: FISH OIL; CALCIUM; VITAMIN B12 [CYANOCOBALAMIN]; LOPERAMIDE

Current Illness:

ID: 1824439
Sex: F
Age:
State: FL

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Headache; Nausea; Joint pain; Muscle pain; Tingling sensation as soon as the vaccine was received in the whole arm plus a little of swollen; Tingling sensation as soon as the vaccine was received in the whole arm plus a little of swollen; Fast heart beat rate; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration on 04May2021 at 10:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient previously took received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration on 13Apr2021 at 10:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. On 04May2021, the patient experienced a tingling sensation as soon as the vaccine was received in the whole arm plus a little of swollen and fast heart beat rate. On 05May2021 at 04:00, the patient experienced headache, nausea, joint pain, muscle pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, nausea, joint pain, muscle pain, tingling sensation, swollen arm and fast heart beat rate was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824440
Sex: M
Age:
State: IA

Vax Date: 05/03/2021
Onset Date: 05/05/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Vertigo/spinning; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 03May2021 at 09:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included heart failure and kidney failure and chronic obstructive pulmonary disease (COPD). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included warfarin (MANUFACTURER UNKNOWN), allopurinol (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and "fu"; all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 08Apr2021 at 09:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 09:30, the patient experienced vertigo, spinning followed by vomiting which happened 4 times in a 24 hour period. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vertigo/spinning and vomiting were resolved with sequelae on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: WARFARIN; ALLOPURINOL; AMLODIPINE; ATORVASTATIN

Current Illness:

ID: 1824441
Sex: F
Age:
State: CT

Vax Date: 05/04/2021
Onset Date: 05/05/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Shortness of breath doing basic things; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 04May2021 at 13:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included seizure disorder, migraines, post-traumatic stress disorder (ptsd), depression, gastroesophageal reflux disease (gerd), over active bladder and allergic to penicillin and sulfas. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included oxybutynin hydrochloride (DITROPAN), fluoxetine hydrochloride (PROZAC), clonazepam (CLONOPIN), topiramate (TROKENDI XR) and gabapentin (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received silybum marianum (DILATIN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 13:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On 05May2021, the patient experienced shortness of breath doing basic things. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event shortness of breath doing basic things was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: DITROPAN; PROZAC; CLONOPIN; TROKENDI XR; GABAPENTIN

Current Illness:

ID: 1824442
Sex: F
Age:
State: OH

Vax Date: 05/06/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Severe body aches; Headache; Fever; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06May2021 at 11:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis and migraine. The patient previously received chlorpromazine (THORAZINE) and infliximab (REMICADE) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included prednisone (MANUFACTURER UNKNOWN) for an unknown indication, from an unknown start date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15Apr2021 at 11:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. On 07May2021 at 06:30, the patient experienced severe body aches, headache and fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events severe body aches, headache and fever was resolved on 07May2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: PREDNISONE

Current Illness:

ID: 1824443
Sex: M
Age:
State:

Vax Date: 03/07/2021
Onset Date: 04/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: This is a spontaneous report from non-contactable consumer based on the information received by Pfizer from Regulatory Authority. (Manufacturer Report Number: 2021_012780). A 63-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Lot Number was not reported) via an unspecified route of administration in Apr2021 (age at the time of vaccination was 63 years) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization and tolvaptan (JINARC) started on 07Mar2021 at 45 mg and 15 mg polycystic kidney disease (congenital cystic kidney disease). The patient current conditions included autosomal dominant polycystic kidney disease (congenital cystic kidney disease). The patient's concomitant medications and laboratory data were not reported. On an unspecified date in Apr2021, the patient had experienced dry eyes after vaccine. No action was taken with Jinarc in response to the event dry eyes. The outcome of the event dry eyes was unknown at the time of this report. Reporter assessment: The event dry eyes was assessed as non-serious, and its causality with respect to Jinarc and Pfizer COVID-19 vaccine was unknown. Regulatory Authority causality assessment: This was a male patient who experienced the event of dry eyes (Dry eye) on an unspecified date in the month of April after initiation of treatment with Jinarc at 45 mg and 15 mg, once a day for autosomal dominant polycystic kidney disease (ADPKD) from 07Mar2021. The event had been assessed as non-serious. The presence of other concomitant drug also presented as a confounding factor, but the causal rote of suspect drug could not been excluded. Moreover, in view of temporal relationship and established safety profile of the drug the event has been assessed as related to the suspect drug. Health authority comment: Not applicable No follow-up attempts were possible, information about lot/batch could not be obtained.

Other Meds: Jinarc

Current Illness: Congenital cystic kidney disease (current condition).

ID: 1824444
Sex: F
Age:
State: CT

Vax Date:
Onset Date: 05/04/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Extreme fatigue; Headache; Pain at injection point; Extreme neck pain; Pain from neck and arm was so bad; Didnt sleep for another 2 days/ Unable to sleep or find relief.; Couldnt move neck; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the right arm on an unknown date as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included propranolol (MANUFACUTURER UNKNOWN), medroxyprogesterone (MANUFACUTURER UNKNOWN) and levonorgestrel (PLAN B), all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on an unknown date as a single dose for COVID-19 immunisation. On 04May2021, the patient experienced extreme fatigue, headache, pain at injection point, extreme neck pain. Could not move neck. Did not sleep for another 2 days. Pain from neck and arm was so bad she had been up crying every night and unable to sleep or find relief. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events extreme fatigue, headache, pain at injection point, extreme neck pain. Could not move neck. Did not sleep for another 2 days. Pain from neck and arm was so bad she had been up crying every night and unable to sleep or find relief was recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: PROPRANOLOL; MEDROXYPROGESTERONE; PLAN B

Current Illness:

ID: 1824445
Sex: F
Age:
State: WA

Vax Date: 05/06/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: itchy red inflammation / lumps on elbows and knees; itchy red inflammation / lumps on elbows and knees; itchy red inflammation / lumps on elbows and knees. The inflammation spread slightly to forearms and there was a small amount on one of ankles.; This is a spontaneous report from a contactable healthcare professional, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the upper left arm on 06May2021 at 11:15 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any known allergies. Concomitant medications included METRONIDAZOLE for an unknown indication on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07May2021 at 00:00, the patient experienced itchy red inflammation/lumps on elbows and knees. The inflammation spread slightly to forearms and there was a small amount on one of ankles. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itchy, red inflammation, lumps on elbows, and knees, the inflammation spread slightly to forearms and there was a small amount on one of ankles was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: METRONIDAZOLE

Current Illness:

ID: 1824446
Sex: F
Age:
State: NJ

Vax Date: 04/30/2021
Onset Date: 05/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Fatigue up to a week after Covid 2nd shot; This is a spontaneous report from a contactable healthcare professional, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 30Apr2021 at 15:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included diet-controlled diabetes mellitus (DM). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 15:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 01May2021 at 08:00, after COVID 2nd shot, the patient experienced fatigue up to a week. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with acupuncture. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fatigue up to a week after Covid 2nd shot was resolved with sequelae on an unknown date in May2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824447
Sex: M
Age:
State: NE

Vax Date: 04/26/2021
Onset Date: 04/27/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Rash on both hands, left hand more severe/ splotchy red marks, about 4 in total/ main rash on left hand hurt and throbbed; Rash on both hands, left hand more severe/ splotchy red marks, about 4 in total/ main rash on left hand hurt and throbbed; Rash on both hands, left hand more severe/ splotchy red marks, about 4 in total/ main rash on left hand hurt and throbbed; Skin started to blister, after blistering, pain stopped and itchy started; Skin started to blister, after blistering, pain stopped and itchy started; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 26Apr2021 at 10:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included sparse migraines and periodic back pain. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medication included cetirizine hydrochloride (ZYRTEC) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8133) via an unspecified route of administration in the right arm on 05Apr2021 at 11:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 27Apr2021 at 06:00, the patient experienced rash on both hands, left hand more severe and splotchy red marks, about 4 in total. It was reported that main rash on left hand hurt and throbbed and skin started to blister, after blistering, pain stopped and itchy started. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash on both hands, left hand more severe/ splotchy red marks, about 4 in total/ main rash on left hand hurt and throbbed and skin started to blister, after blistering, pain stopped and itchy started was resolved with sequelae on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1824448
Sex: M
Age:
State: VA

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: heart rate; Result Unstructured Data: Test Result:My resting heartrate has increased by 10 beats

Allergies:

Symptom List: Pain in extremity

Symptoms: cardiac issues; resting heartrate has increased by 10 beats; ability to do normal activities ceased; This is a spontaneous report from a contactable consumer (patient herself). A male patient of an unspecified age received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. On an unspecified date, the patient experienced cardiac issues. His resting heartrate has increased by 10 beats and he can no longer exercise due to extremely high heart rate. He had 3 years of data of my cardiac output prior to the shot and the day after his ability to do normal activities ceased. On an unspecified date, the patient underwent lab tests and procedures which included heart rate: my resting heartrate has increased by 10 beats. The outcome of the events was unknown. No follow-up attempts are possible; no further information is expected.

Other Meds:

Current Illness:

ID: 1824449
Sex: M
Age:
State: CA

Vax Date: 05/10/2021
Onset Date: 05/10/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Chest pain; Heart palpitation; This is a spontaneous report from a contactable consumer. A 16-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 10May2021 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication taken within two weeks of vaccination was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 18Apr2021 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. On 10May2021, the patient experienced chest pain and heart palpitation. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pain and heart palpitation was resolved on an unknown date in May2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824450
Sex: F
Age:
State: TX

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Nasal swab; Test Result: Negative.

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Extreme dizziness; This is a spontaneous report from a non-contactable nurse, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Mar2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 26Mar2021, the patient experienced extreme dizziness. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On an unknown date, the patient underwent Nasal swab test and the result was negative. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the event extreme dizziness was recovered on an unknown date in 2021. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824451
Sex: M
Age:
State: CO

Vax Date: 05/02/2021
Onset Date: 05/04/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: No upward movement of shoulder after 3rd day of vaccination without severe pain; No upward movement of shoulder after 3rd day of vaccination without severe pain. After day 6 the pain is still there. I can hardly move my shoulder/ arm (left) to close my drivers door.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 02May2021 at 16:15 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and known allergies. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0161) via an unspecified route of administration in the left arm on 11Apr2021 at 16:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 04May2021 at 07:00, the patient experienced no upward movement of shoulder after third day of vaccination without severe pain. After day six, the pain was still there. He could hardly move his shoulder/arm (left) to close his driver's door. The event did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event no upward movement of shoulder after third day of vaccination without severe pain and can hardly move my shoulder/ arm (left) to close drivers door was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824452
Sex: M
Age:
State: IN

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: started feeling a small pain in 'my' right back side, similar to when you have a severe cough; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 16Apr2021 at 07:15(at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included triglycerides high. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included rosuvastatin (MANUFACTURER UNKNOWN) started on an unknown date for unknown indication and unknown if ongoing. On 17Apr2021, the day after the second dose, the patient reported that he felt a small pain in his right back side, similar to a severe cough and the pain was tolerable but last week he had to start taking Ibuprofen (MANUFACTURER UNKNOWN) because the pain became more acute. He would schedule a visit to his doctor this week(as reported). The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event which included treatment with ibuprofen(MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pain in his right back side was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ROSUVASTATIN

Current Illness:

ID: 1824453
Sex: F
Age:
State: CA

Vax Date: 04/26/2021
Onset Date: 04/26/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: I have a poison oak like rash on legs arms back and stomach; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Apr2021 at 11:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to absolute vodka. The patient did not take any concomitant medication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021, the patient had a poison oak like rash on legs arms back and stomach. She was not sure whether it was from the vaccination or was truly poison oak. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event had a poison oak like rash on legs arms back and stomach was unknown at the time of the report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824454
Sex: F
Age:
State: FL

Vax Date: 05/06/2021
Onset Date: 05/06/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210407; Test Name: Body temperature; Result Unstructured Data: Test Result:105.1 Units:[degF]; Comments: fever that went up to a maximum of 105.1 degrees Fahrenheit with a forehead thermometer

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: "I" woke up the next morning with chills; "I" woke up the next morning with chills, body aches; "I" woke up the next morning with chills, body aches, headache; "I" woke up the next morning with chills, body aches, headache, fatigue; "I" woke up the next morning with chills, bodyaches, headache, fatigue, nausea; Fever that went up to a maximum of 105.1 degrees Fahrenheit with a forehead thermometer; 10 hour after injection, "I" developed vomiting; Shoulder is very painful and stiff.; Shoulder is very painful and stiff.; This is a spontaneous report from a contactable nurse, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 06May2021 at 12:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The medical history included renal agenesis (congenital missing kidney), history of left calf deep vein thrombosis (DVT) in 2019 and homozygous for methylenetetrahydrofolate reductase (MTHFR) c677t mutation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included bupropion (MANUFACTURER UNKNOWN), norethindrone (ERRIN) and women's multivitamin(unspecified), all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in right upper arm on 15Apr2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 06May2021, second injection was done very high up in deltoid, almost at joint and the patient's shoulder was very painful and stiff. On 06May2021 at 22:00, the patient developed vomiting. On 07May2021, the next morning the patient woke up with chills, body aches, headache, fatigue, nausea and fever that went up to a maximum of 105.1 degrees fahrenheit with a forehead thermometer. On the same day, the patient underwent body temperature test and the result was found to be 105.1 degrees fahrenheit. Therapeutic measures were taken as a result of the reported events and included treatment with ibuprofen(MANUFACTURER UNKNOWN) 800 mg on an unknown date. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, shoulder was very painful and stiff, vomiting, chills, body aches, fatigue, nausea and fever that went up to a maximum of 105.1 degrees fahrenheit were resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: BUPROPION; ERRIN [NORETHISTERONE]

Current Illness:

ID: 1824455
Sex: F
Age:
State: CA

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: SARS-CoV-2 test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Delayed skin itchiness at site of injection; Arm soreness; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 04May2021 at 10:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications was not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 13Apr2021 at 10:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 14:00, the patient experienced delayed skin itchiness at site of injection and arm soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On an unknown date, the patient underwent SARS-CoV-2 test (nasal swab) and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events delayed skin itchiness at site of injection and arm soreness was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824456
Sex: F
Age:
State: GA

Vax Date: 04/30/2021
Onset Date: 05/05/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Severe rashes all over the body with hives, itching and irritation; Severe rashes all over the body with hives, itching and irritation; Severe rashes all over the body with hives, itching and irritation; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 30Apr2021 at 17:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP8955) via an unspecified route of administration in the left arm on 26Mar2021 at 17:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation and received sulfur (SULPHUR) for an unknown indication on unknown date and experienced drug allergy. On 05May2021 at 18:00, the patient experienced severe rashes all over the body with hives, itching and irritation. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatments with steroids and antihistamines. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe rashes all over the body with hives, itching and irritation was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824457
Sex: F
Age:
State: FL

Vax Date: 03/14/2021
Onset Date: 03/21/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: i have had intense itching at vaccine as well as bumps; i have had intense itching at vaccine as well as bumps; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 14Mar2021 (at the age of 60-year-old), as a single dose for COVID-19 immunisation. Medical history included known allergy to shellfish. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included montelukast (MANUFACTURER UNKNOWN) for unspecified indication from an unknown date and unknown if ongoing. On 21Mar2021, for 8 weeks (as reported at the time of reporting), the patient experienced intense itching at vaccine as well as bumps. Nothing could stop it. The events resulted in emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event intense itching at vaccine as well as bump was not resolved at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on unknown date in 2021 (at the age of 60-year-old), as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds: MONTELUKAST

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am